Predictors of occult nodal metastasis in patients with thin melanoma
- PMID: 20157080
- PMCID: PMC2880665
- DOI: 10.1001/archsurg.2009.271
Predictors of occult nodal metastasis in patients with thin melanoma
Abstract
Hypothesis: Thin primary lesions are largely responsible for the rapid increase in melanoma incidence, making identification of appropriate candidates for nodal staging in this group critically important. We hypothesized that common clinical variables may accurately estimate the risk of nodal metastasis after wide excision and determine the need for sentinel node biopsy.
Design: Review of prospectively acquired data in a large melanoma database.
Setting: A tertiary referral center.
Patients: A total of 2211 patients with thin melanoma treated by wide local excision alone were identified in the database between January 1, 1971, and December 31, 2005. Of those, 1732 met entry criteria.
Main outcome measures: We examined the rate of regional nodal recurrence and the impact of clinical and demographic variables by univariate and multivariate analyses.
Results: The overall nodal recurrence rate was 2.9%; median time to recurrence was 38.3 months. Univariate analysis of 1732 patients identified male sex (P < .001), increased Breslow thickness (P < .001), and increased Clark level (P < .001) as significant for nodal recurrence. Multivariate analysis identified male sex (hazard ratio, 3.5; 95% confidence interval, 1.8-7.0; P < .001), younger age (0.45; 0.24-0.86; P = .001), and increased Breslow thickness (2.5; 1.6-3.7; categorical P < .001) as significant for nodal recurrence. The Clark level was no longer significant (P = .63). Breslow thickness, age, and sex were used to develop a scoring system and nomogram for the risk of nodal involvement. Predictions ranged from 0.1% in the lowest-risk group to 17.4% in the highest-risk group.
Conclusions: Many patients with thin melanoma will have nodal recurrence after wide excision alone. Three simple clinical variables may be used to estimate recurrence risk and select patients for sentinel node biopsy.
Figures
Similar articles
-
Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?Ann Surg Oncol. 2000 Mar;7(2):114-9. doi: 10.1007/s10434-000-0114-x. Ann Surg Oncol. 2000. PMID: 10761789
-
Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.J Am Coll Surg. 2016 Jul;223(1):9-18. doi: 10.1016/j.jamcollsurg.2016.01.045. Epub 2016 Jan 29. J Am Coll Surg. 2016. PMID: 27236435 Free PMC article.
-
Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma.Br J Surg. 2020 Oct;107(11):1480-1488. doi: 10.1002/bjs.11621. Epub 2020 Jun 2. Br J Surg. 2020. PMID: 32484242 Free PMC article.
-
Sentinel node biopsy for head and neck melanoma: a systematic review.Otolaryngol Head Neck Surg. 2011 Sep;145(3):375-82. doi: 10.1177/0194599811408554. Epub 2011 May 3. Otolaryngol Head Neck Surg. 2011. PMID: 21540313 Review.
-
What Should Be the Surgical Technique for Treating Thin Melanoma?NEJM Evid. 2023 May;2(5):EVIDtt2200321. doi: 10.1056/EVIDtt2200321. Epub 2023 Apr 25. NEJM Evid. 2023. PMID: 38320021 Review.
Cited by
-
Dermoscopy for Cutaneous Melanoma: Under the Eye of Both the Dermatologist and the Legal Doctor.Dermatol Pract Concept. 2022 Jul 1;12(3):e2022100. doi: 10.5826/dpc.1203a100. eCollection 2022 Jul. Dermatol Pract Concept. 2022. PMID: 36159108 Free PMC article. Review. No abstract available.
-
Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram.J Clin Oncol. 2020 May 10;38(14):1591-1601. doi: 10.1200/JCO.19.01902. Epub 2020 Mar 13. J Clin Oncol. 2020. PMID: 32167862 Free PMC article.
-
Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota.Mayo Clin Proc. 2012 Apr;87(4):328-34. doi: 10.1016/j.mayocp.2012.01.010. Mayo Clin Proc. 2012. PMID: 22469345 Free PMC article.
-
Thin melanoma and late recurrences: it is never too thin and never too late.Med Oncol. 2014 Apr;31(4):909. doi: 10.1007/s12032-014-0909-4. Epub 2014 Mar 8. Med Oncol. 2014. PMID: 24610543
-
Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy.Cancer Med. 2016 Oct;5(10):2832-2840. doi: 10.1002/cam4.922. Epub 2016 Sep 27. Cancer Med. 2016. PMID: 27671840 Free PMC article.
References
-
- Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93:678–683. - PubMed
-
- McKinnon JG, Yu XQ, McCarthy WH, Thompson JF. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer. 2003;98:1223–1231. - PubMed
-
- Gimotty PA, Guerry D, Ming ME, et al. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol. 2004;22:3668–3676. - PubMed
-
- Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–1317. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous